Month: September 2022
Figure 1
View looking east along the Eureka Zone within a large mafic-ultramafic magmatic complex. Note: Outline of the Ultramafic complex and Eureka zone are approximate.Figure 2
Cross section view of Eureka Zone looking west, showing trace of holes FL-003 and FL-006 drilled by INCO in 1997.VANCOUVER, British Columbia, Sept. 26, 2022 (GLOBE NEWSWIRE) — Millrock Resources Inc. (TSX-V: MRO) (“Millrock”) is pleased to report additional assay results from the sampling of historical core from the Eureka Zone at its 100% owned Nikolai Project, which hosts nickel (Ni) – copper (Cu) – cobalt (Co) – platinum group elements (PGE) prospects.
The Nikolai Project is located within Alaska’s Delta Mining District, approximately 130 kilometers by road south of Delta Junction and approximately 280 kilometers southeast of Fairbanks. The Eureka...
Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures
Written by Customer Service on . Posted in Public Companies.
Broadens Fortilink interbody product line to now include both titanium and 3D-printed polymer options
DEERFIELD, Ill., Sept. 26, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the expansion of its Fortilink product portfolio with the introduction and commercial launch of a new family of interbody fusion devices featuring TiPlus technology.
The new implants include Fortilink-A with TiPlus technology for anterior lumbar interbody fusion (ALIF) procedures; Fortilink-TC and -TS with TiPlus technology for posterior lumbar interbody fusion (PLIF/TLIF) procedures; and Fortilink-C with TiPlus technology for anterior cervical discectomy and fusion (ACDF) procedures.
The new family of...
Mullen Automotive’s ‘Strikingly Different’ Tour Kicks Off in California this October and in Nevada, November 2022
Written by Customer Service on . Posted in Public Companies.
The Mullen FIVE “Strikingly Different” Tour commences on Oct. 27, 2022, at the Rose Bowl in Pasadena, California, and at the Las Vegas Motor Speedway in Las Vegas, Nevada, on Nov. 10, 2022.Mullen to Begin “Strikingly Different” Tour on Oct. 27, 2022
Tour kicks off at the Rose Bowl in Pasadena, California.BREA, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today the kickoff dates of its “Strikingly Different” Tour for the Mullen FIVE EV Crossover.
Mullen is proud to start the “Strikingly Different” Tour with the first stop in California on Oct 27 and 28 at the Rose Bowl in Pasadena, California. From there, the U.S. tour will continue to Las Vegas, Nevada, on Nov....
180 Life Sciences Issues Letter to Stockholders
Written by Customer Service on . Posted in Public Companies.
PALO ALTO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company today released the following letter to stockholders from its Chief Executive Officer, Dr. James Woody.
Dear Fellow Stockholder,
In mid-June, I wrote to update you on the status of our Company and our respective investments.
In that letter, I provided an update regarding the Company’s clinical development plans, which remained on track then, and continue to remain on track today. As a reminder, 180 Life Sciences was founded on the belief that novel anti-inflammatory biologics that are already approved, such as anti-tumor necrosis factor (TNF), or adalimumab, could have the potential to address large unmet needs for a variety of additional indications. Currently,...
Paratek Pharmaceuticals to Host Investor Update on the Global Opportunity in Non-Tuberculous Mycobacteria (NTM)
Written by Customer Service on . Posted in Public Companies.
Oct. 3 Webinar Features Presentations by Scientific Leaders in NTM and Paratek’s Management Team
BOSTON, Sept. 26, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use today announces that the company will host an update for investors on the global opportunity for NUZYRA® (omadacycline) in non-tuberculous mycobacteria (NTM) on Monday, Oct. 3 from 10:30 a.m. to noon Eastern time.
During the webinar, Paratek Chief Executive Officer Evan Loh, M.D., and Chief Development and Regulatory Officer Randy Brenner will provide a corporate overview, update investors on the market opportunity for NTM...
LM Funding Commences Generation of Bitcoin Mining Revenue
Written by Customer Service on . Posted in Public Companies.
TAMPA, FL, Sept. 26, 2022 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ:LMFA) (“LM Funding” or “LMFA”) today announced the energization of 848 S19J Pro Antminer Mining Machines (S19J Pro) at the Core Scientific Inc. facility in Calvert City, Kentucky.
“We are excited to energize our first machines in my home state of Kentucky,” said Bruce M. Rodgers, Chairman and CEO of LM Funding and a Bowling Green, Kentucky native. “We plan to sell our mined Bitcoin to pay operating expenses and reinvest the balance in the purchase and operation of additional Bitcoin mining machines.” Rodgers finished by stating, “Generating Bitcoin revenue marks the successful execution to date of our cryptocurrency mining business strategy and next phase of growth for our Company. We continue to believe all 5,400 machines will...
Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer Awards
Written by Customer Service on . Posted in Public Companies.
WOBURN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics and medical device industries, has awarded the previously nominated Ameluz® marketing campaign, created by Biofrontera Inc. along with Elevate Healthcare, “Relaunch/Revitalization of the Year” and “Professional Website/Online Initiative of the Year” awards. These awards were announced at the 14th Annual Trailblazer Awards held September 22, 2022 in New York, where they also recognized the previously announced Trailblazer Brand Champion in Dermatology, Leslie Hopkins, Associate Director of Marketing at Biofrontera Inc. The winners will be featured...
HUMBL and Great Foods2Go Announce Strategic Technology Partnership
Written by Customer Service on . Posted in Public Companies.
San Diego-based companies will collaborate on technology solutions for cloud kitchen and delivery services
San Diego, California, Sept. 26, 2022 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC Markets: HMBL) announced today the formation of a strategic technology partnership with Great Foods2Go (GF2GO).
Under the terms of the agreement, the two companies will integrate HUMBL’s mobile application, search engine and marketplace technologies in support of GF2GO and its sub-brand, 1Delivery.
The partnership will utilize the full HUMBL platform including: HUMBL Wallet, HUMBL Pay, HUMBL Search Engine and HUMBL Marketplace technologies.
The partnership will focus initially on the San Diego, California cloud kitchen location and be designed to expand across multiple locations.
The location currently prepares and delivers over 2,000 food orders per...
Form 8.3 – [EMIS Group plc – 23 09 2022] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
EMIS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position held/dealing...
Form 8.3 – [GB Group plc – 23 09 2022] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
GB GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position held/dealing...